ACT receives patent because of its single-blastomere technology Advanced Cellular Technology.

ACT receives patent because of its single-blastomere technology Advanced Cellular Technology, Inc. , a head in neuro-scientific regenerative medicine, announced today that it has been issued a patent on its ‘single-blastomere’ technique.’ The single-blastomere technology runs on the one-cell biopsy approach similar to pre-implantation genetic medical diagnosis , which is trusted in the in vitro fertilization procedure and does not hinder the embryo’s developmental potential prescription drugs .D., chief scientific officer of Take action, stated, ‘This patent issuance represents reputation of the technology underlying our single-blastomere technology.

.. ACS, ASMBS disappointed with CMS’ decision on bariatric surgery for Medicare patients Groups Say Decision May Lead to Higher Risk of Mortality for Medicare Bariatric Surgical Individuals Despite strong opposition from leading surgical and medical organizations, the Centers for Medicare & Medicaid Services offers ruled it will no longer require Medicare patients to undergo bariatric surgical treatments at accredited facilities. Today that eligible Medicare patients may have bariatric operations performed at any center they choose CMS ruled, even those services with little encounter in handling high-risk patients.

You Might Also Like